To the editor: Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolitic anemia to anti-CD20 monoclonal antibody

被引：20

作者：

Iannitto, E ^{[1
]}

Ammatuna, E ^{[1
]}

Marino, C ^{[1
]}

Cirrincione, S ^{[1
]}

Greco, G ^{[1
]}

Mariani, G ^{[1
]}

机构：

[1] Univ Palermo, Haematol & Bone Marrow Transplantat Unit, I-90127 Palermo, Italy

来源：

BLOOD | 2002年 / 99卷 / 03期

关键词：

D O I：

10.1182/blood.V99.3.1096a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1096 / 1097

页数：2

共 3 条

[1] Rituximab therapy of patients with B-cell chronic lymphocytic leukemia [J].

Huhn, D ;

von Schilling, C ;

Wilhelm, M ;

Ho, AD ;

Hallek, M ;

Kuse, R ;

Knauf, W ;

Riedel, U ;

Hinke, A ;

Srock, S ;

Serke, S ;

Peschel, C ;

Emmerich, B .

BLOOD, 2001, 98 (05) :1326-1331

[2] Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features [J].

Mauro, FR ;

Foa, R ;

Cerretti, R ;

Giannarelli, D ;

Coluzzi, S ;

Mandelli, F ;

Girelli, G .

BLOOD, 2000, 95 (09) :2786-2792

[3] Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome [J].

Seipelt, G ;

Böhme, A ;

Koschmieder, S ;

Hoelzer, D .

ANNALS OF HEMATOLOGY, 2001, 80 (03) :170-173

← 1 →